EPS Bio Technology Corp. (TPEX:4183)
13.00
-0.05 (-0.38%)
May 29, 2026, 1:00 PM CST
EPS Bio Technology Market Cap
EPS Bio Technology has a market cap or net worth of 309.4 million as of May 29, 2026. Its market cap has decreased by -44.44% in one year.
Market Cap
309.40M
Enterprise Value
350.71M
Revenue
443.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.00
Market Cap Chart
Since November 13, 2012, EPS Bio Technology's market cap has decreased from 354.00M to 309.40M, a decrease of -12.60%. That is a compound annual growth rate of -0.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 309.40M | -21.69% |
| Dec 31, 2025 | 395.08M | -28.45% |
| Dec 31, 2024 | 552.16M | -12.29% |
| Dec 29, 2023 | 629.51M | 42.97% |
| Dec 30, 2022 | 440.30M | 0.54% |
| Dec 30, 2021 | 437.92M | -14.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rossmax International | 1.15B |
| Wiltrom | 1.04B |
| S&S Healthcare Holding | 904.05M |
| PlexBio | 846.82M |
| Radiant Innovation | 804.76M |
| AmCad BioMed | 706.16M |
| Carilex Medical | 687.29M |
| Health & Life | 516.74M |